This release summarises the diagnoses in 2019 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours)

In 2019, approximately 61 men and 43 women per 100,000 population died from lung cancer in England. The North East of England had the highest mortality from lung cancer for both genders with a rate of approximately 80 men and 66 women per 100,000 population.

Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.

In the period 2017 to 2019, the mortality rate from melanoma skin cancer in the United Kingdom was 4.8 deaths per 100,000 for men and 2.8 deaths per 100,000 for women. Across the overall provided time interval the mortality rate from skin cancer has increased significantly in the UK, although there has been a slight decline since 2012-2014.

This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.

In 2018/19, the mortality rate from non-melanoma skin cancer in the United Kingdom was 2.3 deaths per 100 thousand for men and 0.8 deaths per 100 thousand for women. Across the provided time interval the mortality rate from non-melanoma skin cancer has decreased for women, while the rate for men has experienced more fluctuations but was a higher rate at the start and the end of the provided time interval.

In the period 2017 to 2019, the mortality rate from kidney cancer in the United Kingdom was 10.4 deaths per 100,000 men and 5.1 deaths per 100,000 women. Across the overall provided time interval the mortality rate from kidney cancer has increased in the UK, although the rate has been fairly stable in recent years.

In 2021, approximately 666 males per 100,000 and 557 females per 100,000 in England were newly diagnosed with cancer, excluding non-melanoma skin cancer. Overall, the diagnosis rate for males showed a slight decreasing trend over the years, while the rate for females remained relatively stable with minor changes. This statistic shows the rate of newly diagnosed cases of cancer per 100,000 population in England from 2018 to 2021, by gender.

The Get Data Out programme from the National Disease Registration Service publishes detailed statistics about small groups of cancer patients in a way that ensures patient anonymity is maintained. The Get Data Out programme currently covers 15 cancer sites. This data release is a corrected re-release of detailed statistics for 2013-2019 treatment data. The correction means that surgery counts are no longer slightly underreported. There are some small changes in group sizes of usually no more than 2%, although this is larger for non-melanoma skin cancers. The 15 cancer sites now covered by Get Data Out are: ‘Bladder, Urethra, Renal Pelvis and Ureter’, ‘Bone cancer’, ‘Brain, meningeal and other primary CNS tumours’, ‘Eye cancer’, ‘Head and neck’, ‘Kaposi sarcoma’, ‘Kidney’, ‘Oesophageal and Stomach’, ‘Ovary, fallopian tube and primary peritoneal carcinomas’, ‘Pancreas’, ‘Prostate’, ‘Sarcoma’, ‘Skin tumours’, ‘Soft tissue and peripheral nerve cancer’, ‘Testicular tumours including post-pubertal teratomas’. Anonymisation standards are designed into the data by aggregation at the outset. Patients diagnosed with a certain type of tumour are divided into many smaller groups, each of which contains approximately 100 patients with the same characteristics. These groups are aimed to be clinically meaningful and differ across cancer sites. For each group of patients, Get Data Out routinely publish statistics about incidence, routes to diagnosis, treatments and survival. All releases and documentation are available on the Get Data Out main technical page. Before using the data, we recommend that you read the guide for first time users. The data is available in an open format for anyone to access and use. We hope that by releasing anonymous detailed data like this we can help researchers, the public and patients themselves discover more about cancer. If you have feedback or any other queries about Get Data Out, please email us at NDRSenquires@nhs.net and mention 'Get Data Out' in your email.

Survival estimates for children (aged 0 to 14 years) diagnosed with cancer in England from 2001 to 2017.

Smoothed life tables for use in cancer survival, by sex, index of multiple deprivation, age and region of England.

This statistic shows the number of deaths from cervical cancer in England from 2014 to 2021. In 2021, the number of deaths from cervical cancer reached 702, an increase from 681 deaths in 2020.

This file contains the digital vector boundaries for Cancer Alliances, in England, as at 1 July 2019.

The boundaries available are: (BFC) Full resolution - clipped to the coastline (Mean High Water mark). Contains both Ordnance Survey and ONS Intellectual Property Rights. Units for the following fields:st_length = metresst area = metres²Download File Sizes Full resolution - clipped to the coastline (11.2 MB) REST URL of ArcGIS for INSPIRE View Service – https://ons-inspire.esriuk.com/arcgis/rest/services/Health_Boundaries/Cancer_Alliances_July_2019_EN_BFC/MapServer/exts/InspireView REST URL of ArcGIS for INSPIRE Feature Download Service – https://ons-inspire.esriuk.com/arcgis/rest/services/Health_Boundaries/Cancer_Alliances_July_2019_EN_BFC/MapServer/exts/InspireFeatureDownload REST URL of Feature Access Service – https://ons-inspire.esriuk.com/arcgis/rest/services/Health_Boundaries/Cancer_Alliances_July_2019_EN_BFC/FeatureServer

This file contains the digital vector boundaries for Cancer Alliances, in England, as at 1 July 2019. The BGC boundaries are generalised (20m) - clipped to the coastline (Mean High Water mark). Contains both Ordnance Survey and ONS Intellectual Property Rights.REST URL of ArcGIS for INSPIRE View Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Cancer_Alliances_(July_2019)_GCB_EN/MapServerREST URL of ArcGIS for INSPIRE Feature DownloadService – https://dservices1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/services/Cancer_Alliances_July_2019_Generalised_Clipped_Boundaries_EN/WFSServer?service=wfs&request=getcapabilitiesREST URL of Feature Access Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Cancer_Alliances_July_2019_GCB_EN_2022/FeatureServer

This file contains the digital vector boundaries for Cancer Alliances, in England, as at 1 July 2019. The BUC boundaries are ultra generalised (500m) - clipped to the coastline (Mean High Water mark). Contains both Ordnance Survey and ONS Intellectual Property Rights.REST URL of ArcGIS for INSPIRE View Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Cancer_Alliances_(July_2019)_UGB_EN/MapServerREST URL of ArcGIS for INSPIRE Feature DownloadService – https://dservices1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/services/Cancer_Alliances_July_2019_Ultra_Generalised_Boundaries_EN/WFSServer?service=wfs&request=getcapabilitiesREST URL of Feature Access Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Cancer_Alliances_July_2019_UGB_EN_2022/FeatureServer

Directly age standardised mortality rate from breast cancer for females in the respective time period per 100,000 registered female patients. October 2022: This is the last CCGOIS publication. All Clinical Commissioning Groups (CCGs) were statutorily abolished on the 1 July 2022, and from this point all statutory obligations are managed by the Integrated Care Boards (ICBs). ICBs were established as statutory bodies from July 2022 and succeed Sustainability and Transformation Partnerships (STPs). These came into effect on 1 July 2022. A transition phase has been implemented from 1 July 2022, during which the 106 Organisation Data Service (ODS) codes that identified CCGs will be temporarily retained, but the names will be changed to identify the ‘Sub ICB Location’. March 2020: In addition to the changes in March 2019, the indicator production process has been fully automated. As a result there are two changes to this publication: 1) Data in this file are published for 2016-2018 only; all data is based on the most recent methodology. For the historic time series of this indicator please refer to the zip files in the June 2018 publication: https://digital.nhs.uk/data-and-information/publications/clinical-indicators/ccg-outcomes-indicator-set/archive/ccg-outcomes-indicator-set---june-2018 Please note, neither version of the file contains data for 2015-2017; changes in the data processing meant the 2015 data was not comparable to the 2016 and 2017 data processed under the new method. 2) Data are run against CCGs which were in existence at the time of processing. As of the March 2019 release the processing of the Primary Care Mortality Database (PCMD) and the standard population used to calculate the indicator for new data periods changed; this file now contains only those data periods processed under the new method. For the historic time series of this indicator please refer to the June 2018 publication referenced above. Legacy unique identifier: P01819